Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway

[1]  Rafaela Scalco Ferreira,et al.  Non-cytotoxic Concentration of Cisplatin Decreases Neuroplasticity-Related Proteins and Neurite Outgrowth Without Affecting the Expression of NGF in PC12 Cells , 2016, Neurochemical Research.

[2]  B. Yoo,et al.  Propolis Inhibits Neurite Outgrowth in Differentiating SH-SY5Y Human Neuroblastoma Cells , 2016, Toxicological research.

[3]  Yun-Sik Choi,et al.  Neuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicity , 2016, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[4]  E. Giovannetti,et al.  Platinum-induced neurotoxicity and preventive strategies: past, present, and future. , 2015, The oncologist.

[5]  Rafaela Scalco Ferreira,et al.  Caffeic acid phenethyl ester (CAPE) protects PC12 cells from MPP+ toxicity by inducing the expression of neuron-typical proteins. , 2014, Neurotoxicology.

[6]  R. Brkljača,et al.  Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. , 2014, Food & function.

[7]  G. Murtaza,et al.  Caffeic Acid Phenethyl Ester and Therapeutic Potentials , 2014, BioMed research international.

[8]  S. Z. Abdel‐Rahman,et al.  Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: A review on its anti‐inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects , 2013, IUBMB life.

[9]  F. Longo,et al.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease , 2013, Nature Reviews Drug Discovery.

[10]  O. Baffa,et al.  Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats , 2013, Neuroscience.

[11]  R. Pi,et al.  Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells , 2013, Neuroscience Letters.

[12]  Y. Kurauchi,et al.  Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor , 2012, British journal of pharmacology.

[13]  S. Pluchino,et al.  A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection , 2011, Molecular Neurodegeneration.

[14]  M. Khazaei,et al.  Cannabinoid Receptor Agonist WIN-55,212-2 Protects Differentiated PC12 Cells From Organophosphorus- Induced Apoptosis , 2010, International journal of toxicology.

[15]  E. Calabrese.  Enhancing and Regulating Neurite Outgrowth , 2008, Critical reviews in toxicology.

[16]  A. Burton,et al.  Chronic pain in the cancer survivor: a new frontier. , 2007, Pain medicine.

[17]  M. Kanter,et al.  Role of caffeic acid phenethyl ester, an active component of propolis, against NAOH-induced esophageal burns in rats. , 2006, International journal of pediatric otorhinolaryngology.

[18]  E. Uzar,et al.  The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester. , 2006, Toxicology.

[19]  F. Lieberman,et al.  Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. , 2006, Seminars in oncology.

[20]  J. Schimmelpfeng,et al.  Quantification of NGF-dependent neuronal differentiation of PC-12 cells by means of neurofilament-L mRNA expression and neuronal outgrowth , 2004, Journal of Neuroscience Methods.

[21]  E. Oztaş,et al.  Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. , 2004, Free radical biology & medicine.

[22]  A. Kizilay,et al.  Caffeic Acid Phenethyl Ester Ameliorated Ototoxicity Induced by Cisplatin in Rats , 2004, Journal of chemotherapy.

[23]  William R Mundy,et al.  Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. , 2004, Neurotoxicology and teratology.

[24]  P. Lazarovici,et al.  Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.

[25]  A. Bast,et al.  Transcription factor NF-κB as a potential biomarker for oxidative stress , 2001, British Journal of Nutrition.

[26]  C. Leonetti,et al.  Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Blair H. Smith,et al.  Chronic pain , 2000, The Lancet.

[28]  J. Flaskos,et al.  The effects of carbaryl and trichlorphon on differentiating mouse N2a neuroblastoma cells. , 1999, Toxicology letters.

[29]  H. Çıralık,et al.  The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[30]  J. Verweij,et al.  Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Aryeh Routtenberg,et al.  GAP-43: an intrinsic determinant of neuronal development and plasticity , 1997, Trends in Neurosciences.

[32]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Kaplan,et al.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.

[34]  C. Feighery,et al.  Neurofilament expression in human T lymphocytes. , 1993, Immunology.

[35]  G. Thiel,et al.  Synapsin I, Synapsin II, and Synaptophysin: Marker Proteins of Synaptic Vesicles , 1993, Brain pathology.

[36]  M. Barbacid,et al.  K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. , 1992, Oncogene.

[37]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[38]  J. Albers,et al.  Interventions for preventing neuropathy caused by cisplatin and related compounds. , 2011, The Cochrane database of systematic reviews.

[39]  E. Odacı,et al.  Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin‐induced nephrotoxicity in rats , 2004, Journal of applied toxicology : JAT.

[40]  F. Biering-Sørensen,et al.  Signaling Pathways , 2003 .

[41]  R. Labianca,et al.  Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Yves-Alain Barde,et al.  The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. , 2002, Nature neuroscience.

[43]  B. Hallberg,et al.  Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[44]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[45]  Y. Fang,et al.  Induction of axon-like and dendrite-like processes in neuroblastoma cells , 1998, Journal of neurocytology.

[46]  S. Cascinu,et al.  Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.